Assignee
KANGLIN BIOTECHNOLOGY HANGZHOU CO LTD
CN·0 granted patents·2 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
2 records- 0148US2024352096A1Gene sequence construct for gene therapy of human immunodeficiency virus infectionKANGLIN BIOTECHNOLOGY HANGZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0248US2024391981A1Gene sequence construct for gene therapy for hiv infectionKANGLIN BIOTECHNOLOGY HANGZHOU CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KANGLIN BIOTECHNOLOGY HANGZHOU CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →